Free Submission Public Relations &
Deutsch English


Market Report, "Benitec Biopharma Limited - Product Pipeline Review - 2012", published

Print article Print article
2013-01-28 07:08:41 - New Pharmaceuticals research report from Global Markets Direct is now available from Fast Market Research

Global Market Direct's pharmaceuticals report, "Benitec Biopharma Limited - Product Pipeline Review - 2012" provides data on the Benitec Biopharma Limited's research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct's proprietary databases, Benitec Biopharma Limited's corporate website, SEC filings, investor presentations and featured press releases, both from Benitec Biopharma Limited and industry-specific third party sources, put together by Global Markets Direct's team.


* Benitec Biopharma Limited - Brief Benitec Biopharma Limited overview including business description, key information and facts, and its locations and subsidiaries.
* Review of current pipeline of

Benitec Biopharma Limited human therapeutic division.
* Overview of pipeline therapeutics across various therapy areas.
* Coverage of current pipeline molecules in various stages of drug development, including the combination treatment modalities, across the globe.
* Product profiles for late stage and clinical stage products of Benitec Biopharma Limited with complete description of the product's developmental history, mechanism of action, therapeutic class, target and major milestones.
* Recent updates of the Benitec Biopharma Limited's pipeline in the last quarter.
* Key discontinued and dormant projects.
* Latest news and deals relating to the products.

Full Report Details at
- ..

Reasons to buy

* Evaluate Benitec Biopharma Limited's strategic position with total access to detailed information on its product pipeline.
* Assess the growth potential of Benitec Biopharma Limited in its therapy areas of focus.
* Identify new drug targets and therapeutic classes in the Benitec Biopharma Limited's R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
* Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps.
* Exploit collaboration and partnership opportunities with Benitec Biopharma Limited.
* Avoid Intellectual Property Rights related issues.
* Explore the dormant and discontinued projects of Benitec Biopharma Limited and identify potential opportunities in those areas.

Partial Table of Contents:

Table of Contents
Table of Contents
List of Tables
List of Figures
Benitec Biopharma Limited Snapshot
Benitec Biopharma Limited Overview
Key Information
Key Facts
Benitec Biopharma Limited - Research and Development Overview
Key Therapeutic Areas
Benitec Biopharma Limited - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Benitec Biopharma Limited - Pipeline Products Glance
Benitec Biopharma Limited - Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Benitec Biopharma Limited - Drug Profiles
ddRNAi Program For Cancer-Associated Pain
Product Description
Mechanism of Action
R&D Progress
ddRNAi Program For Hepatitis B
Product Description
Mechanism of Action
R&D Progress
ddRNAi Program For Oculopharyngeal Muscular Dystrophy
Product Description
Mechanism of Action
R&D Progress
Drug-Resistant Lung Cancer Program
Product Description
Mechanism of Action
R&D Progress
Product Description
Mechanism of Action
R&D Progress
Product Description
Mechanism of Action
R&D Progress
Benitec Biopharma Limited - Pipeline Products by Route of Administration
Benitec Biopharma Limited - Pipeline Products By Mechanism of Action
Benitec Biopharma Limited - Recent Pipeline Updates
Benitec Biopharma Limited - Company Statement
Benitec Biopharma Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Benitec Biopharma Limited, Recent Developments
Benitec Biopharma Limited- Press Release
Dec 18, 2012: Benitec Appoints Synteract For Phase I/IIa Clinical Trial Of TT-034 In Hepatitis C
Dec 03, 2012: Benitec Biopharma's Muscular Dystrophy Program Demonstrates Significant Gene Silencing
Nov 13, 2012: Benitec Biopharma's Tribetarna Demonstrates High Delivery And Significant Gene-Silencing In Lung Cancer Program
Financial Deals Landscape
Benitec Biopharma Limited, Deals Summary
Benitec Biopharma Limited, Pharmaceuticals & Healthcare, Deal Details
Benitec Biopharma Enters Into An Agreement With Stanford University
Benitec Enters Into Agreement With Children's Cancer Institute Australia for Medical Research
Benitec Enters Into Co-Development Agreement With Biomics Biotechnologies
Licensing Agreements
Benitec Amends RNAi Licensing Agreement With CSIRO
uniQure Enters Into Licensing Agreement With Benitec Biopharma For RNA Interference Technology
Benitec Biopharma Enters Into Licenising Agreement With uniQure
Benitec Biopharma Enters Into Licensing Agreement With Genable Technologies
Benitec Enters Into Licensing Agreement With Calimmune For ddRNAi Technology
Benitec Obtains Rights To T cell HIV Therapeutic
Benitec Enters Into Licensing Agreement With City of Hope
Benitec Enters Into Licensing Agreement With Tacere Therapeutics
Equity Offering
Benitec Completes Rights Issue Of $8.45 Million
Benitec Completes Rights Issue Of $0.7 Million
Benitec Completes Private Placement Of $1.36 Million
Benitec Completes Right Offering Of $4.57 Milion
Debt Offering
Benitec Raises $0.5 Million In Private Placement Of Convertible Notes.

Full Table of Contents is available at:

About Global Markets Direct

Global Markets Direct is a leading provider of global business intelligence and market analysis. It publishes a range of high quality company and market reports created by its large research and analysis capability and drawing from its extensive unique databases of industry-specific information. View more research from Global Markets Direct at

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at or call us at 1.800.844.8156.

Bill Thompson
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact